An Early Phase 2 Study to Explore the Efficacy and Safety of JTZ-951 in Patients with Anemia and Chronic Kidney Disease Not Requiring Dialysis <Anemia Correction study>

Trial Profile

An Early Phase 2 Study to Explore the Efficacy and Safety of JTZ-951 in Patients with Anemia and Chronic Kidney Disease Not Requiring Dialysis <Anemia Correction study>

Completed
Phase of Trial: Phase II

Latest Information Update: 15 Jun 2016

At a glance

  • Drugs JTZ 951 (Primary)
  • Indications Anaemia
  • Focus Therapeutic Use
  • Sponsors Japan Tobacco
  • Most Recent Events

    • 15 Jun 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top